Stockscreener 앱 받기
6.23
14.10%
0.77
시간 외 거래:
6.23
전일 마감가:
$5.46
열려 있는:
$5.42
하루 거래량:
66,451
Relative Volume:
1.17
시가총액:
$215.98M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-5.2823
EPS:
-1.1794
순현금흐름:
$-46.21M
1주 성능:
+1.63%
1개월 성능:
+25.10%
6개월 성능:
+22.16%
1년 성능:
+19.12%
1일 변동 폭
$5.41
$6.24
1주일 범위
$4.98
$6.38
52주 변동 폭
$4.22
$11.69
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
HC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy Recommendation - MSN
Trading (OBIO) With Integrated Risk Controls - Stock Traders Daily
Orchestra BioMed Appoints John Mack to Board of Directors - MSN
SkyView Investment Advisors LLC Invests $163,000 in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Fashion Network
Interactive Bible Study Course Demonstrated to Over 200 Individuals at International Fair in Angola - JW News
Orchestra BioMed executive sells over $73k in company stock - Investing.com India
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of Stock - MarketBeat
Orchestra BioMed director sells over $30k in company shares - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells $41,705.70 in Stock - Defense World
Have Orchestra BioMed Holdings Insiders Been Selling Stock? - Simply Wall St
Orchestra BioMed executive sells over $120k in company stock - Investing.com India
Insider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of Stock - MarketBeat
Orchestra BioMed executive sells over $120k in company stock By Investing.com - Investing.com UK
Orchestra BioMed Initiates BackBeat Pivotal Study Of AVIM Therapy - MPO-mag
Orchestra BioMed (NASDAQ:OBIO) Receives New Coverage from Analysts at HC Wainwright - MarketBeat
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com
HC Wainwright Begins Coverage on Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates - MSN
David P. Hochman Acquires 2,500 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock - Defense World
Chardan Capital Comments on Orchestra BioMed Holdings, Inc.’s FY2024 Earnings (NASDAQ:OBIO) - Defense World
Research Analysts Set Expectations for Orchestra BioMed Holdings, Inc.'s FY2024 Earnings (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Forecasted to Earn Q3 2024 Earnings of ($0.43) Per Share - Defense World
Q3 2024 Earnings Estimate for Orchestra BioMed Holdings, Inc. Issued By B. Riley (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Announces Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates - MSN
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Price T Rowe Associates Inc. MD Sells 51,533 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Investment Analysis - Stock Traders Daily
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):